Login
Cart
Support
Search
Search
Search
Home
eSymposia
ePanels
SciTalks
Virtual Recaps
Event Summary
Sessions
More
Support
Preferred
(EDT)
Beyond Effector T Cell Therapeutics
5:00 PM - 8:00 PM EST
Tuesday, January 26, 2021
Room: Multi Tech Session
Archive
Co-Chairs
Saar Gill
,
PhD
University of Pennsylvania
Megan Levings
,
PhD
University of British Columbia
Other
Beyond Effector T Cell Therapeutics
Engineered Macrophage Therapeutics
5:00 PM - 5:25 PM EST
Tuesday, January 26, 2021
Room: V300 Guy Coombes
Archive
Speaker
Saar Gill
, PhD
University of Pennsylvania
Beyond Effector T Cell Therapeutics
NK Cell Therapies for Cancer
5:25 PM - 5:50 PM EST
Tuesday, January 26, 2021
Room: V300 Guy Coombes
Archive
Speaker
Dan Kaufman
, MD
University of California, San Diego
Beyond Effector T Cell Therapeutics
Programming Bacteria as a Cancer Therapy
5:50 PM - 6:15 PM EST
Tuesday, January 26, 2021
Room: V300 Guy Coombes
Archive
Speaker
Tal Danino
, PhD
Columbia University
Beyond Effector T Cell Therapeutics
Coffee Break
6:15 PM - 6:40 PM EST
Tuesday, January 26, 2021
Coffee Break
NextGen Treg Therapies
6:40 PM - 7:05 PM EST
Tuesday, January 26, 2021
Archive
Speaker
Megan Levings
, PhD
University of British Columbia
Beyond Effector T Cell Therapeutics
Synthetic Biology Tools for the Development of Engineered Stem Cell Therapeutics
7:05 PM - 7:30 PM EST
Tuesday, January 26, 2021
Archive
Speaker
Tara Deans
, PhD
University of Utah
Beyond Effector T Cell Therapeutics
Short Talk: Engraftment of Gene-Engineered Human Plasma Cells in Humanized Mice Shows Early Promise for the Feasibility of Novel Plasma Cell-Based Therapies
7:30 PM - 7:45 PM EST
Tuesday, January 26, 2021
Archive
Speaker
Tyler Hill
, BS
University of Washington
Beyond Effector T Cell Therapeutics
×
Evaluation
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by
clicking here
.
Close this Window